• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Curis, Inc.

NASDAQ:CRIS

$4.60 -$0.06 (-1.29%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

Investing in Small-Cap Stocks: Anomalies are Golden

4/4/2012 by Nasdaq

Wall Street Loves These Stocks. Should You?

3/21/2012 by DailyFinance

Being Right in Biotech Is Only Half the Battle

3/15/2012 by DailyFinance

March Madness, Biotech Style

2/29/2012 by DailyFinance

Prized Bio Assets Come in Small Packages

2/13/2012 by Nasdaq

Maximum Market: $2.9 Billion, For Now

2/1/2012 by DailyFinance

This Just In: More Upgrades and Downgrades

1/31/2012 by DailyFinance

This Drug Approval Is Good For the Industry

1/31/2012 by DailyFinance

US FDA Approves Roche and Curis Skin Cancer Drug

1/30/2012 by Smart Money

UPDATE:FDA Approves Roche's Erivedge For Basal Cell Skin Cancer

1/30/2012 by Smart Money

In Drug Development, Help Is Crucial

11/30/2011 by DailyFinance

Investing 101: Rallying Stocks Under $5 Undervalued to Analyst Estimates

7/18/2011 by Nasdaq

UPDATE: Roche 'Hedgehog Inhibitor' Shrinks Basal Cancer Tumors -Study

4/2/2011 by Smart Money

Best Performing U.S. Stocks Year to Date

3/28/2011 by Seeking Alpha

Roche's Oral Skin Cancer Drug Meets Mid-Stage Trial Goals

3/21/2011 by Smart Money

UPDATE: Roche's Skin Cancer Drug Meets Mid-Stage Trial Goals

3/21/2011 by Smart Money

Curis' 'Hedgehog' Inhibitor to Offer Hope for Basal Cell Carcinoma Sufferers

2/28/2011 by Seeking Alpha

Which of These Small Stocks Can Climb Even Higher?

1/28/2011 by Seeking Alpha

9 Biotech Stocks for 2011

1/13/2011 by Seeking Alpha

Biotech’s Top and Bottom 10 From 2010

1/6/2011 by Seeking Alpha

8 Cancer Innovators to Watch

11/9/2010 by Seeking Alpha

Did the Market Overreact to Curis's Latest Setback?

8/11/2010 by Seeking Alpha

Synta Is Heating Up

8/9/2010 by Seeking Alpha

Curis Tumbles As Roche Colon Cancer Trial Fails

6/16/2010 by Smart Money

Curis, Roche drug combats children's brain tumors

6/5/2010 by Reuters

UPDATE: Bristol Drug Extends Survival In Skin-Cancer Trial

6/5/2010 by Smart Money

2nd UPDATE: Bristol Drug Extends Survival In Skin-Cancer Trial

6/5/2010 by Smart Money

Cancer Meeting To Shine Spotlight On Bristol-Myers' Research

6/1/2010 by Smart Money

UPDATE 1-Curis gets milestone payments from Debiopharm

2/12/2010 by Reuters

UPDATE 1-Curis to raise $16.25 mln from share offering

1/22/2010 by Reuters